Page last updated: 2024-08-25

methotrexate and Immunoglobulin G4-Related Disease

methotrexate has been researched along with Immunoglobulin G4-Related Disease in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Chen, Y; Cong, Y; Dong, L; Omar, D1
Bian, W; Chen, D; Chen, J; Fu, J; Li, Y; Li, Z; Liu, Y; Sun, X; Zhang, W; Zhang, Y; Zhao, X1
Chen, D; Gao, J; Li, ZG; Liu, Y; Shen, D; Wang, K; Wang, Y; Wang, Z; Xia, C; Yang, F; Yu, G; Zeng, Q; Zhang, S; Zhu, L1
Chen, D; Lao, M; Yang, X; Yang, Z; Zhan, Z1
Fei, Y; Feng, R; Lai, Y; Peng, L; Wang, L; Wang, M; Zeng, X; Zhang, F; Zhang, P; Zhang, W; Zhang, X; Zhao, Y1
Bansie, RD; Karim, AF; Paridaens, D; Rombach, SM; van Hagen, PM; Van Laar, JAM; Verdijk, RM1

Reviews

1 review(s) available for methotrexate and Immunoglobulin G4-Related Disease

ArticleYear
Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis.
    Rheumatology (Oxford, England), 2020, 04-01, Volume: 59, Issue:4

    Topics: Antirheumatic Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Mycophenolic Acid; Network Meta-Analysis; Odds Ratio; Recurrence; Remission Induction; Rituximab; Tacrolimus

2020

Other Studies

5 other study(ies) available for methotrexate and Immunoglobulin G4-Related Disease

ArticleYear
Efficacy and safety of iguratimod on patients with relapsed or refractory IgG4-related disease.
    Clinical rheumatology, 2020, Volume: 39, Issue:2

    Topics: Adult; Aged; Chromones; Cyclophosphamide; Female; Glucocorticoids; Humans; Immunoglobulin G; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Lacrimal Apparatus; Leflunomide; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisone; Recurrence; Retrospective Studies; Salivary Glands; Sulfonamides; Treatment Outcome; Young Adult

2020
Relapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort.
    Rheumatology (Oxford, England), 2020, 08-01, Volume: 59, Issue:8

    Topics: Adult; Age Factors; Azathioprine; Biomarkers; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunoglobulin G; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome

2020
Immunoglobulin G4-Related Disease Presenting as Bilateral Arthritis of the Hip Joints.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2018, Volume: 24, Issue:7

    Topics: Adolescent; Antirheumatic Agents; Arthralgia; Arthritis; Arthroplasty, Replacement, Hip; Diagnosis, Differential; Hip Joint; Humans; Immunoglobulin G; Immunoglobulin G4-Related Disease; Immunohistochemistry; Magnetic Resonance Imaging; Male; Methotrexate; Prednisone; Radiography; Treatment Outcome

2018
Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients.
    Arthritis research & therapy, 2018, 04-10, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Child; Cohort Studies; Cyclophosphamide; Cyclosporine; Female; Glucocorticoids; Glycosides; Humans; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Leflunomide; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisone; Prospective Studies; Remission Induction; Treatment Outcome; Young Adult

2018
The treatment outcomes in IgG4-related disease.
    The Netherlands journal of medicine, 2018, Volume: 76, Issue:6

    Topics: Adrenal Cortex Hormones; Adult; Aged; Antirheumatic Agents; Autoimmune Diseases; Cohort Studies; Cyclophosphamide; Female; Follow-Up Studies; Humans; Immunoglobulin G; Immunoglobulin G4-Related Disease; Male; Methotrexate; Middle Aged; Netherlands; Recurrence; Retrospective Studies; Risk Assessment; Rituximab; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult

2018